On February 6, 2025, the 「Enrofloxacin Granules」 submitted by The United Animal Healthcare (Inner Mongolia) Co., Ltd. was officially approved as a Class IV national new veterinary drug. Meanwhile, the veterinary drug product 「Streptomycin Sulfate for Injection」 was approved for registration modification.
Enrofloxacin Granules are mainly used to treat respiratory diseases in pigs caused by susceptible bacteria such as Streptococcus and Haemophilus parasuis. The product can rapidly relieve symptoms, effectively reduce the risk of disease deterioration, and significantly improve farming efficiency. Streptomycin sulfate exhibits strong antibacterial activity against various Gram-negative bacilli, including Escherichia coli, Pasteurella, Salmonella, Brucella, and Proteus species. The product is widely used in the market due to its high cost-effectiveness, delivering reliable therapeutic outcomes while reducing farming costs.